Three New Product Patents for Suven Life Sciences

by Julia Samuel on  December 31, 2014 at 3:47 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

Suven Life Sciences Ltd has secured one product patent each from Eurasia, Japan and one from Mexico for its New Chemical Entities (NCEs).
Three New Product Patents for Suven Life Sciences
Three New Product Patents for Suven Life Sciences

A patent is a grant made by a government that confers upon the creator of an invention the sole right to make, use, and sell that invention for a set period of time.

The granted claims of the patents include the class of selective 5-HT compounds discovered by Suven and are being developed as therapeutic agents.

"They are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer's disease, Attention Deficient Hyperactivity Disorder (ADHD), Huntington's disease, Parkinson and Schizophrenia" Suven said in a release on Tuesday.

With these new patents, Suven has 13 patents from Eurasia, 12 from Japan and 17 from Mexico. The patents may be out-licensed at phase 1 or phase 2 of clinical development, as they are the exclusive products of Suven. These patents are valid till 2029.

Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive